The impact of comorbid anxiety and depression on alcohol treatment outcomes

The impact of comorbid anxiety and depression on alcohol treatment outcomes
复制标题

DOI:
10.1111/j.1360-0443.2005.001069.x
复制
发表时间:
2005-06-01
期刊:
影响因子:
6
通讯作者:
O'Neill, K
O'Neill, K
中科院分区:
医学1区
文献类型:
--
作者:
Burns, L;Teesson, M;O'Neill, K

文献摘要

被引文献

相似文献

目的 本研究探讨了共病《诊断与统计手册》第四版 (DSM-IV) 焦虑和/或抑郁对酒精问题门诊治疗的影响。设计前瞻性相关设计。参与者和设置在两个治疗地点寻求酒精门诊治疗的 71 名客户在酒精问题治疗开始时接受了采访,并在 3 个月后使用相同的措施进行了重新采访。共病 DSM-IV 焦虑和/或抑郁症通过综合国际诊断访谈 (CIDI) 进行测量,这是世界卫生组织开发的一项综合访谈,旨在评估当前和一生中精神障碍的患病率。结果指标包括标准化的残疾指标[简式 (SF)-12 心理健康总结评分和停止工作的天数]以及平均饮酒量。客户还被要求评价他们对所接受服务的满​​意度。 结果发现,与没有这些共病的参与者相比,患有 DSM-IV 焦虑症和/或抑郁症的参与者在开始治疗时的残疾程度更高,饮酒量更大。在 3 个月的随访中,两组参与者(即患有或不患有 DSM-IV 共病焦虑和/或抑郁症的参与者)的残疾程度均显着减轻,平均饮酒场合的饮酒量也显着低于基线。尽管如此,在随访中,共病组仍然比非共病组更加残疾,饮酒量也更多。 结论 需要进一步研究来确定对于共病 DSM-IV 焦虑和/或抑郁的酒精治疗寻求者最合适的护理模式。
Aims This study examines the impact of comorbid Diagnostic and Statistical Manual version IV (DSM-IV) anxiety and/or depression on out-patient treatment for alcohol problems.Design A prospective correlational design.Participants and settings Seventy-one clients seeking alcohol out-patient treatment at two treatment sites were interviewed at commencement of a treatment episode for alcohol problems and reinterviewed using the same measures 3 months later. Comorbid DSM-IV anxiety and/or depression were measured by the Composite International Diagnostic Interview (CIDI), a comprehensive interview developed by the World Health Organization to assess current and life-time prevalence of mental disorders. Outcome measures included standardized measures of disability [the short form (SF)-12 Mental Health Summary Score and the number of days taken out of role] and the average amount of alcohol consumed. Clients were also asked to rate their satisfaction with the services received.Findings Participants with comorbid DSM-IV anxiety and/or depressive disorders were more disabled and drank more heavily than those without these comorbid disorders at entry to treatment. At 3-month follow-up both groups of participants (i.e. those with and without DSM-IV comorbid anxiety and/or depression) were significantly less disabled and also drank significantly less alcohol on an average drinking occasion than at baseline. Despite this, the comorbid group remained more disabled and drank more heavily than the noncomorbid group at follow-up.Conclusions Further research is needed to determine the most appropriate model of care for alcohol treatment seekers with comorbid DSM-IV anxiety and/or depression.